Monograph: Certolizumab Pegol (Rec.INN)
Index Nominum
Search in Index Nominum
All databases
Certolizumab Pegol (Rec.INN)
This content is only available to registered users
If you’re visiting this website the first time and would like to test the database free of charge for ten days, then click here to register once. After you’ve registered, log in with your user name and password.You’re already registered with DrugBase and would like to test the database free of charge for ten days without any further commitment? Then log in here with your access data and select the database you wish to test.
- Latin:
- Certulizumabum pegolum
- German:
- Certulizumab pegol
- French:
- Certulizumab pégol
- Spanish:
- Certulizumab pegol
Therapeutical categories:
Immunosuppressant
Monoclonal antibody
Tumor necrosis factor alpha (TNF-α) inhibitor
Monoclonal antibody
Tumor necrosis factor alpha (TNF-α) inhibitor
ATC:
- L: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > L04: IMMUNOSUPPRESSANTS > L04A: IMMUNOSUPPRESSANTS > L04AB: Tumor necrosis factor alpha (TNF-Ã) inhibitors > L04AB05: Certolizumab pegol
- Q: VETERINARY > QL: ANTINEOPLASTIC AND IMMUNOMODULATING AGEN > QL04: IMMUNOSUPPRESSANTS > QL04A: IMMUNOSUPPRESSANTS > QL04AB: Tumor necrosis factor alpha (TNF-Ã) inhi > QL04AB05: Certolizumab pegol [vet.]
CAS-No.:
0428863-50-7
